Experiencing this symptom?
Use the Symptom Checker to find related conditions
Sweating
Also known as Diaphoresis, Cold sweat, Hidrosis, and Perspiration
Perspiration (sweating, transpiration, or diaphoresis) is the production of fluids secreted by the sweat glands in the skin of mammals. Two types of sweat glands can be found in humans: Eccrine glands and apocrine glands. The eccrine sweat glands are distributed over much of the body.
Source: WikipediaWhat causes it?
The most common causes of sweating are pneumonia, menopause, and chronic obstructive pulmonary disease (copd). Other possible causes, such as heart failure, are more rare.
What symptoms are related?
Within all the people who go to their doctor with sweating, 55% report having shortness of breath, 55% report having sharp chest pain, and 51% report having nausea.
What might my doctor prescribe?
Common Tests and Procedures
Patients with sweating often receive hematologic tests, complete blood count, radiographic imaging procedure, electrocardiogram, glucose measurement, plain x-ray, electrolytes panel and kidney function tests .
Common Medications
The most commonly prescribed drugs for patients with sweating include aluminum chloride hexahydrate topical, ethambutol, acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine, efavirenz, pentoxifylline, tenofovir, onabotulinumtoxina (botox), estradiol / levonorgestrel, methylnaltrexone (relistor), aminophylline / amobarbital / ephedrine, rifabutin, pyrazinamide and saxagliptin (onglyza) .
| Aluminum Chloride Hexahydrate Topical | ||
| Ethambutol | $80 (28 days) | |
| Efavirenz | $516 (28 days) | |
| Pentoxifylline | $18 (28 days) | |
| Tenofovir | ||
| Onabotulinumtoxina (Botox) | $1100 (28 days) | |
| Methylnaltrexone (Relistor) | $478 (21 days) | |
| Rifabutin | $471 (28 days) | |
| Pyrazinamide | $71 (28 days) | |
| Saxagliptin (Onglyza) | $176 (28 days) |
Who is at risk?
Groups of people at highest risk for sweating include .
Age
| < 1 years | 0.2x | |
| 1-4 years | 0.1x | |
| 5-14 years | 0.3x | |
| 15-29 years | 0.9x | |
| 30-44 years | 1.2x | |
| 45-59 years | 1.3x | |
| 60-74 years | 1.2x | |
| 75+ years | 1.2x |
Sex
| Male | 1.1x | |
| Female | 0.9x |
Race/Ethnicity
| Black | 1.0x | |
| Hispanic | 0.7x | |
| White | 1.1x | |
| Other | 1.0x |
Loading...